China SXT Pharmaceuticals Inc (NASDAQ:SXTC) Short Interest Down 49.0% in August

China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 142,300 shares, a decrease of 49.0% from the July 31st total of 278,900 shares. Currently, 1.7% of the shares of the company are sold short. Based on an average daily volume of 40,800 shares, the days-to-cover ratio is presently 3.5 days.

Institutional investors have recently made changes to their positions in the company. Jane Street Group LLC purchased a new stake in shares of China SXT Pharmaceuticals in the second quarter worth about $72,000. Invesco Ltd. purchased a new stake in shares of China SXT Pharmaceuticals in the second quarter worth about $88,000. Finally, Spark Investment Management LLC purchased a new stake in shares of China SXT Pharmaceuticals in the first quarter worth about $94,000. 7.67% of the stock is currently owned by hedge funds and other institutional investors.

Shares of China SXT Pharmaceuticals stock traded down $0.05 on Friday, reaching $2.35. The stock had a trading volume of 901 shares, compared to its average volume of 12,401. China SXT Pharmaceuticals has a 1 year low of $1.97 and a 1 year high of $23.35. The business’s 50 day moving average is $2.44 and its two-hundred day moving average is $4.21.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.

Recommended Story: What economic reports are most valuable to investors?

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.